Search Articles

View query in Help articles search

Search Results (1 to 10 of 101 Results)

Download search results: CSV END BibTex RIS

CSV download: Download all 101 search results (up to 5,000 articles maximum)

Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study

Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study

To address the challenges of modeling rare diseases in SCs, we conducted an exploratory pilot study with the following objectives: (1) to enhance the representation of Fabry disease within an SC by incorporating insights from guided interviews with experts.

Anne Pankow, Nico Meißner-Bendzko, Jessica Kaufeld, Laura Fouquette, Fabienne Cotte, Stephen Gilbert, Ewelina Türk, Anibh Das, Christoph Terkamp, Gerhard-Rüdiger Burmester, Annette Doris Wagner

JMIR AI 2025;4:e55001


Current Practice and Expert Perspectives on Cultural Adaptations of Digital Health Interventions: Qualitative Study

Current Practice and Expert Perspectives on Cultural Adaptations of Digital Health Interventions: Qualitative Study

We purposively chose interviews over a literature review because the current DHI literature primarily provides superficial descriptions of the adaptation processes. Instead, interviewing experts allows for a deeper and more nuanced understanding of current practice, challenges, and gaps, and provides experience-based recommendations. Interviews were concluded once we reached thematic saturation.

Vasileios Nittas, Sarah J Chavez, Paola Daniore

JMIR Mhealth Uhealth 2025;13:e59965


Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders

Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders

The underlying interviews and corresponding transcripts, have already been examined for existing problems and barriers in the context of AI-based CDSS from the perspective of experts. There is some evidence of problems and barriers, but as the field of AI-based CDSS is relatively new, little is known about how to optimize its use. Therefore, qualitative research in the form of expert interviews was conducted to approach the topic in an explorative way.

Godwin Denk Giebel, Pascal Raszke, Hartmuth Nowak, Lars Palmowski, Michael Adamzik, Philipp Heinz, Marianne Tokic, Nina Timmesfeld, Frank Martin Brunkhorst, Jürgen Wasem, Nikola Blase

JMIR Med Inform 2025;13:e69688


Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

The mixed methods approach, including financial modeling, surveys, and interviews, lends credibility to the findings, while the focus on sustained-release dosage forms highlights a specific and practical application. The paper is well structured and contributes meaningfully to the discussion on enhancing local pharmaceutical capabilities. However, there are areas where clarity, presentation, and depth can be improved to strengthen its impact. 1.

Elena Shkarupeta

JMIRx Med 2025;6:e77627


Authors’ Response to Peer Reviews of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Authors’ Response to Peer Reviews of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

We conducted in-depth interviews with 15 participants, ensuring data saturation in accordance with qualitative research methodology. Among them, 5 were local company owners specializing in IMD development, as they provided firsthand insights into industry challenges and opportunities. The remaining participants included experts from various sectors of IMD advancement, such as regulatory affairs, financial modeling, and clinical development, ensuring a comprehensive and diverse perspective.

Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub

JMIRx Med 2025;6:e77623


Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

The qualitative component included a literature review, surveys, and expert interviews, while the quantitative component focused on financial modeling and analysis. A comprehensive review of existing IMD dosage forms, manufacturing processes, cost structures, regulatory requirements, and market trends was conducted using Pub Med, Scopus, and industry reports. This review served as input for the development of the financial model and interview guide.

Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub

JMIRx Med 2025;6:e65978


Implementation of a Quality Improvement and Clinical Decision Support Tool for Cancer Diagnosis in Primary Care: Process Evaluation

Implementation of a Quality Improvement and Clinical Decision Support Tool for Cancer Diagnosis in Primary Care: Process Evaluation

The semistructured interviews were conducted over the phone. The interviews were conducted by study researchers (SC, NL, and BH; see the following section on researcher characteristics). The duration of the interviews ranged between 15 and 42 minutes. The interview guides were developed using the Clinical Performance Feedback Intervention Theory framework [34] and were pilot-tested during earlier optimization work on the FHT cancer module [27].

Sophie Chima, Barbara Hunter, Javiera Martinez-Gutierrez, Natalie Lumsden, Craig Nelson, Dougie Boyle, Kaleswari Somasundaram, Jo-Anne Manski-Nankervis, Jon Emery

JMIR Cancer 2025;11:e65461


An Exergames Program for Adolescents With Type 1 Diabetes: Qualitative Study of Acceptability

An Exergames Program for Adolescents With Type 1 Diabetes: Qualitative Study of Acceptability

To understand the acceptability of Exer T1 D, we conducted semistructured interviews with all enrollees to complement quantitative evaluations reported elsewhere, in which participant acceptability of this intervention was demonstrated with results from survey data [19].

Selene S Mak, Laura M Nally, Juanita Montoya, Rebecca Marrero, Melissa DeJonckheere, Kevin L Joiner, Soohyun Nam, Garrett I Ash

JMIR Diabetes 2025;10:e65665


Parents’ Motivations for Calling an Out-of-Hours Helpline: Qualitative Study

Parents’ Motivations for Calling an Out-of-Hours Helpline: Qualitative Study

Included parents for interviews. MH1813: Medical Helpline 1813; RCT: randomized controlled trial. Parents unable to participate in a telephone interview or calling regarding an injury were asked to self-exclude, as the videos did not cover injuries, and they may have differed in their motivations for calling MH1813. A total of 6 interviews appeared to be related to injuries of the child.

Liv Borch-Johnsen, Fredrik Folke, Marianne Sjølin Frederiksen, Morten Schrøder, Gorm Greisen, Stine Lund, Vibeke Zoffmann, Caroline Gren, Tine Tjørnhøj-Thomsen, Dina Cortes

J Med Internet Res 2025;27:e66780